Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avara has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility.
read more
Wednesday, January 06, 2021
Aurobindo Pharma and COVAXX have entered into an agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and UNICEF.
read more
Monday, September 25, 2017
Atox Bio today announced that it has been awarded the next option on a performance-based contract with the BARDA for the development of Reltecimod in patients with NSTI.
read more
AtkinsRéalis Group Inc. an engineering services and nuclear company has been chosen by Jubilant HollisterStier to provide detailed design for the expansion of their sterile injectable facility in Montreal as part of Canada's Biomanufacturing and Life...
read more
Asymchem Laboratories announced that it has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K., marked with a ribbon cutting by Dr. Hao Hong, Chairman, Founder, and CEO of ...
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
Asymchem announced its Tianjin1 site successfully completed a FDA general GMP reinspection conducted between January 14-18, 2019. No Form 483 was issued.
read more
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer.
read more
ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (referred to as DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing...
read more
Wednesday, August 31, 2022
Ashland announced a strategically significant expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.
read more
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, announces the U.S. Food and Drug Administration (FDA) has approved ASI's ...
read more
Wednesday, January 28, 2015
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, is pleased to announce the U.S Food and Drug Administration (FDA) has approved...
read more
(BUSINESS WIRE) – Ash Stevens, Inc., a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce receipt of a 2014 Lilly Global Supplier ...
read more
Monday, December 13, 2021
Ascensus Specialties announced its acquisition of Wychem Limited, a UK-based manufacturer of fine chemicals for pharmaceutical and specialty applications. This transaction complements Ascensus’ existing capabilities and reinforces the Company’s focus...
read more